Literature DB >> 24824132

Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS).

Ashley Crook1, Loren Plunkett2, Laura E Forrest3, Nina Hallowell4, Samantha Wake2, Kathryn Alsop5, Margaret Gleeson6, David Bowtell7, Gillian Mitchell8, Mary-Anne Young3.   

Abstract

Population-based genetic research may produce information that has clinical implications for participants and their family. Researchers notify participants or their next of kin (NoK) about the availability of genetic information via a notification letter; however, many subsequently do not contact a family cancer centre (FCC) to clarify their genetic status. Therefore, the purpose of this study was to examine research participants' experience of receiving a notification letter and the factors that influenced contact with an FCC. Twenty-five semi-structured interviews were conducted with research participants (n=10) or their NoK (n=15) who had received a notification letter following participation in the Australian Ovarian Cancer Study. There were a number of factors which impacted participants' access to genetic counselling at an FCC. Some participants had unmet information and support needs, which were addressed by their participation in this psychosocial interview study. Recruitment and participation in this study therefore inadvertently increased a number of participants' intention to contact an FCC. For others, participation in this study facilitated access to an FCC. Recommendations are proposed regarding future notification as well as implications for clinical practice. An approach that also provides opportunity to address research participants' support and informational needs before contacting a clinical genetics service as well as practical guidance for accessing genetic services would facilitate timely and smooth access for research participants who are interested in following up clinically relevant genetic test results.

Entities:  

Mesh:

Year:  2014        PMID: 24824132      PMCID: PMC4297914          DOI: 10.1038/ejhg.2014.86

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

1.  "For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.

Authors:  Claire E Wakefield; Paboda Ratnayake; Bettina Meiser; Graeme Suthers; Melanie A Price; Jessica Duffy; Kathy Tucker
Journal:  Genet Test Mol Biomarkers       Date:  2011-01-23

2.  'Coming down the line'-- patients' understanding of their family history of common chronic disease.

Authors:  Fiona M Walter; Jon Emery
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

3.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

4.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.

Authors:  Kathryn Alsop; Sian Fereday; Cliff Meldrum; Anna deFazio; Catherine Emmanuel; Joshy George; Alexander Dobrovic; Michael J Birrer; Penelope M Webb; Colin Stewart; Michael Friedlander; Stephen Fox; David Bowtell; Gillian Mitchell
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

5.  Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.

Authors:  Kurt D Christensen; J Scott Roberts; David I Shalowitz; Jessica N Everett; Scott Y H Kim; Leon Raskin; Stephen B Gruber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-09       Impact factor: 4.254

6.  The emergence of an ethical duty to disclose genetic research results: international perspectives.

Authors:  Bartha Maria Knoppers; Yann Joly; Jacques Simard; Francine Durocher
Journal:  Eur J Hum Genet       Date:  2006-07-26       Impact factor: 4.246

7.  How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry.

Authors:  Louise A Keogh; Douglass Fisher; Sherri Sheinfeld Gorin; Sheri D Schully; Jan T Lowery; Dennis J Ahnen; Judith A Maskiell; Noralane M Lindor; John L Hopper; Terrilea Burnett; Spring Holter; Julie L Arnold; Steven Gallinger; Mercy Laurino; Mary-Jane Esplen; Pamela S Sinicrope
Journal:  J Community Genet       Date:  2013-05-24

8.  Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications?

Authors:  Louise A Keogh; Christine M van Vliet; David M Studdert; Judith A Maskiell; Finlay A Macrae; D James St John; Clara L Gaff; Mary Anne Young; Melissa C Southey; Graham G Giles; Doreen A Rosenthal; John L Hopper; Mark A Jenkins
Journal:  Med J Aust       Date:  2009-09-07       Impact factor: 7.738

9.  The legal risks of returning results of genomics research.

Authors:  Ellen Wright Clayton; Amy L McGuire
Journal:  Genet Med       Date:  2012-02-09       Impact factor: 8.822

10.  The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer Study.

Authors:  Nina Hallowell; Kathryn Alsop; Margaret Gleeson; Ashley Crook; Loren Plunkett; David Bowtell; Gillian Mitchell; Mary-Anne Young
Journal:  Genet Med       Date:  2013-02-28       Impact factor: 8.822

View more
  7 in total

1.  Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer.

Authors:  Erin Tutty; Lara Petelin; Joanne McKinley; Mary-Anne Young; Bettina Meiser; Victoria M Rasmussen; Rowan Forbes Shepherd; Paul A James; Laura E Forrest
Journal:  Eur J Hum Genet       Date:  2019-04-08       Impact factor: 4.246

2.  Timing and context: important considerations in the return of genetic results to research participants.

Authors:  Kate A McBride; Nina Hallowell; Martin H N Tattersall; Judy Kirk; Mandy L Ballinger; David M Thomas; Gillian Mitchell; Mary-Anne Young
Journal:  J Community Genet       Date:  2015-05-26

3.  Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.

Authors:  Amanda M Willis; Sian K Smith; Bettina Meiser; Mandy L Ballinger; David M Thomas; Martin Tattersall; Mary-Anne Young
Journal:  J Genet Couns       Date:  2018-02-17       Impact factor: 2.537

4.  My Research Results: a program to facilitate return of clinically actionable genomic research findings.

Authors:  Amanda M Willis; Bronwyn Terrill; Angela Pearce; Alison McEwen; Mandy L Ballinger; Mary-Anne Young
Journal:  Eur J Hum Genet       Date:  2021-10-04       Impact factor: 4.246

5.  TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.

Authors:  Rachel Delahunty; Linh Nguyen; Stuart Craig; Belinda Creighton; Dinuka Ariyaratne; Dale W Garsed; Elizabeth Christie; Sian Fereday; Lesley Andrews; Alexandra Lewis; Sharne Limb; Ahwan Pandey; Joy Hendley; Nadia Traficante; Natalia Carvajal; Amanda B Spurdle; Bryony Thompson; Michael T Parsons; Victoria Beshay; Mila Volcheck; Timothy Semple; Richard Lupat; Kenneth Doig; Jiaan Yu; Xiao Qing Chen; Anna Marsh; Christopher Love; Sanela Bilic; Maria Beilin; Cassandra B Nichols; Christina Greer; Yeh Chen Lee; Susan Gerty; Lynette Gill; Emma Newton; Julie Howard; Rachel Williams; Christie Norris; Andrew N Stephens; Erin Tutty; Courtney Smyth; Shona O'Connell; Thomas Jobling; Colin J R Stewart; Adeline Tan; Stephen B Fox; Nicholas Pachter; Jason Li; Jason Ellul; Gisela Mir Arnau; Mary-Anne Young; Louisa Gordon; Laura Forrest; Marion Harris; Karen Livingstone; Jane Hill; Georgia Chenevix-Trench; Paul A Cohen; Penelope M Webb; Michael Friedlander; Paul James; David Bowtell; Kathryn Alsop
Journal:  J Clin Oncol       Date:  2022-03-09       Impact factor: 50.717

6.  The Clinical and Psychosocial Outcomes for Women Who Received Unexpected Clinically Actionable Germline Information Identified through Research: An Exploratory Sequential Mixed-Methods Comparative Study.

Authors:  Laura E Forrest; Rowan Forbes Shepherd; Erin Tutty; Angela Pearce; Ian Campbell; Lisa Devereux; Alison H Trainer; Paul A James; Mary-Anne Young
Journal:  J Pers Med       Date:  2022-07-07

7.  Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast Cancer.

Authors:  Angela R Bradbury; Linda Patrick-Miller; Brian L Egleston; Kara N Maxwell; Laura DiGiovanni; Jamie Brower; Dominique Fetzer; Jill Bennett Gaieski; Amanda Brandt; Danielle McKenna; Jessica Long; Jacquelyn Powers; Jill E Stopfer; Katherine L Nathanson; Susan M Domchek
Journal:  JCO Precis Oncol       Date:  2018-04-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.